New Methods of Collaboration in AI and Data Science
We’re very excited about the latest research collaboration with Janssen France between The Janssen Pharmaceutical Companies of Johnson & Johnson’s Computational Sciences and Immunology R&D teams and the Institut Pasteur, working with Greater Paris University Hospitals - AP-HP.
Johnson & Johnson Innovation is focused on accelerating all stages of innovation worldwide and has facilitated the collaboration. The initiative aims to advance our understanding of chronic inflammation and its role in initiating and progressing chronic inflammatory diseases. Moreover, the approach is fully aligned with France’s ambition to become a leader in Artificial Intelligence in Healthcare.
This collaboration allows us to work together in the hope of advancing our understanding of the role certain chronic inflammation has with regards to specific autoimmune diseases. The goal is to recruit patients and obtain bio-samples alongside associated phenotypic data to unlock insights into disease biology that will transform the way we treat inflammatory diseases.